GlassScriptPhysician profile
Steve Kang
NPI 1538393889
$2,726.67
in general payments reported to CMS, 2019-2025
15 companies · $779 in 2025
The $779 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $142 · 2021: $88.58 · 2022: $74.20 · 2023: $774 · 2024: $296 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,848.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,202.02 | 2020-2025 | Augment Injectable, Inbone, Prophecy |
| Medtronic, INC. | $661.03 | 2024-2025 | Micra, Cobalt Dr Mri Surescan, Omniasecure Mri Surescan |
| Wright Medical Technology, INC. | $293.94 | 2019 | |
| Boston Scientific Corporation | $114.51 | 2024 | |
| Allergan, INC. | $109.19 | 2019 | |
| Biotissue Holdings INC. | $108.75 | 2025 | |
| Depuy Synthes Sales INC. | $61.31 | 2019 | |
| Zimmer Biomet Holdings, INC. | $39.61 | 2019 | |
| Medtronic Vascular, INC. | $35.20 | 2019 | |
| Abbott Laboratories | $29.07 | 2020-2024 | Amplatzer Amulet |
| Heron Therapeutics, INC. | $22.40 | 2021 | |
| Integra Lifesciences Corporation | $20.30 | 2019 | |
| Tactile Systems Technology INC | $14.96 | 2020 | |
| Bioventus LLC | $14.38 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Kang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.